The Substance Abuse and Mental Health Services Administration today postponed the effective date of its final rule on confidentiality of substance use disorder patient records to March 21. The Office of Management and Budget last month published a memorandum calling for heads of executive departments and agencies to postpone for review for 60 days most regulations that have been published in the Federal Register but not yet taken effect. For those regulations that “raise substantial questions of law or policy,” the memorandum calls for agencies to “take further appropriate action in consultation with the OMB director.” AHA had urged SAMHSA to align the final rule, the first major update to the confidentiality rule since 1987, with the Health Insurance Portability and Accountability Act.

Related News Articles

Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and…
Headline
Eligible organizations can apply through May 6 for up to $1 million each for a three-year period to expand opioid and other substance use disorder services in…
Insights and Analysis
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.
Headline
The Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies today held a hearing to review what programs and…
Headline
Food and Drug Administration Commissioner Scott Gottlieb, M.D., yesterday announced the agency’s 2019 agenda to address the opioid epidemic.